The immunogenic properties of an E1-deleted, human adenovirus type 5 (Ad5) vaccine virus with activity against rabies were examined in mice, foxes and dogs using different routes of administration. NMRI mice received 105·8, 105·3, 104·3, 103·3 and 102·3 TCID50 by peroral or intramuscular (i.m.) administration. Furthermore, six mice received 105·8 TCID50 intracerebrally (i.c.). The construct elicited marked seroconversion in mice after oral administration. Immunoreactivity in mice was even more pronounced i.m. and i.c. After direct oral administration (108·0 TCID50) in foxes, six of eight animals developed rabies virus-neutralizing antibodies (VNA). All foxes immunized by direct injection (107·7 TCID50) in the membrane of the jejunum were shown to seroconvert. Pre-existing immunity against canine adenovirus did not hinder the development of rabies VNA after oral application of the construct (108·0 TCID50). Fox cubs (24–29 days old) born from rabies-immune vixens were shown to develop very high levels of rabies VNA after i.m. administration (108·0 TCID50), indicating that the immunogenicity of the construct could surpass maternally transferred immunity. In dogs, the construct (108·0 TCID50) induced a very strong immune response after i.m. administration. However, no immune response was detectable in dogs after direct oral administration (108·3 TCID50) or after endoscopic deposition in the smaller intestine (108·0 TCID50). Hence, it must be concluded that the construct is not suitable for oral vaccination of dogs against rabies.
Anonymous.1978; WHO informal consultation on reference preparations and potency tests for rabies vaccines. Developments in Biological Standardization 40:265–271
BerknerK. L.,
SharpP. A.1985; Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant. Nucleic Acids Research 13:841–857
CharltonK. M.,
ArtoisM.,
PrevecL.,
CampbellJ. B.,
CaseyG. A.,
WandelerA. I.,
ArmstrongJ.1992; Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Archives of Virology 123:169–179
CoxJ. H.,
SchneiderL. G.1976; Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine. Journal of Clinical Microbiology 3:96–101
FooksA. R.,
JeevarajahD.,
LeeJ.,
WarnesA.,
NiewieskS.,
ter MeulenV.,
StephensonJ. R.,
CleggJ. C. S.1998; Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents. Journal of General Virology 79:1027–1031
GarcelonD. K.,
WayneR. K.,
GonzalesB. J.1992; A serologic survey of the island fox ( Urocyon littoralis ) on the Channel Islands, California. Journal of Wildlife Diseases 28:223–229
GeseE. M.,
SchultzR. D.,
JohnsonM. R.,
WilliamsE. S.,
CrabtreeR. L.,
RuffR. L.1997; Serological survey for diseases in free-ranging coyotes ( Canis latrans ) in Yellowstone National Park, Wyoming. Journal of Wildlife Diseases 33:47–56
HammondJ. M.,
McCoyR. J.,
JansenE. S.,
MorrissyC. J.,
HodgsonA. L. M.,
JohnsonM. A.2000; Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever. Vaccine 18:1040–1050
LaurensonK.,
Van HeerdenJ.,
StanderP.,
Van VuurenM. J.1997; Seroepidemiological survey of sympatric domestic and wild dogs ( Lycaon pictus ) in Tsumkwe District, north-eastern Namibia. Onderstepoort Journal of Veterinary Research 64:313–316
MayrA.,
BachmannP. A.,
BibrackB.,
WittmannG.1977Virologische Arbeitsmethoden Band II. Jena: Gustav Fischer;
MonteilM.,
Le PottierM. F.,
RistovA. A.,
CarioletR.,
L’HospitalierR.,
KlonjkowskiB.,
EloitM.2000; Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies. Vaccine 18:1738–1742
MüllerT.,
SchusterP.,
VosA.,
SelhorstT.,
WenzelU.,
NeubertA.2001; Effect of maternal immunity on the immune response of young foxes to oral vaccination against rabies with SAD B19. American Journal of Veterinary Research (in press)
NeubertA.,
SchusterP.,
MüllerT.,
VosA.,
PommereningE.2001; Immunogenicity and efficacy of the oral rabies vaccine SAD B19 in foxes. Journal of Veterinary Medicine B 48:179–183
PappZ.,
MiddletonD. M.,
MittalS. K.,
BabiukL. A.,
Baca-EstradaM. E.1997; Mucosal immunization with recombinant adenoviruses: induction of immunity and protection of cotton rats against respiratory bovine herpesvirus type 1 infection. Journal of General Virology 78:2933–2943
PrevecL.,
CampbellJ. B.,
ChristieB. S.,
BelbeckL.,
GrahamF. L.1990; A recombinant human adenovirus vaccine against rabies. Journal of Infectious Diseases 161:27–30
SchmidtM. R.,
PiekosB.,
CabatinganM. S.,
WoodlandR. T.2000; Expression of a human coxsackie/adenovirus receptor transgene permits adenovirus infection of primary lymphocytes. Journal of Immunology 165:4112–4119
SchneiderL. G.,
CoxJ. H.1983; Ein Feldversuch zur oralen Immunisierung von Füchsen gegen die Tollwut in der Bundesrepublik Deutschland. I. Unschädlichkeit, Wirksamkeit und Stabilität der Vakzine SAD B19. Tierärztliche Umschau 38:315–324
SchusterP.,
MüllerT.,
VosA.,
SelhorstT.,
NeubertL.,
PommereningE.2001; Comparative immunogenicity and efficacy studies with oral rabies vaccine SAD P5/88 in raccoon dogs and foxes. Acta Veterinaria Hungarica (in press)
SmithJ. S.,
YagerP. A.,
BaerG. M.1973; A rapid reproducible test for determining rabies neutralizing antibody. Bulletin of the World Health Organization 48:535–541
SpencerJ. A.,
BinghamJ.,
HeathR.,
RichardsB.1999; Presence of antibodies to canine distemper virus, canine parvovirus and canine adenovirus type 1 in free-ranging jackals ( Canis adustus and Canis mesomelas ) in Zimbabwe. Onderstepoort. Journal of Veterinary Research 66:251–253
TruyenU.,
MüllerT.,
HeidrichR.,
TackmannK.,
CarmichaelL. E.1998; Survey on viral pathogens in wild red foxes ( Vulpes vulpes ) in Germany with emphasis on parvoviruses and analysis of a DNA sequence from a red fox parvovirus. Epidemiology and Infection 121:433–440
Von SeggernD. J.,
NemerowG. R.1999; Adenoviral vectors for protein expression. In Gene Expression Systems: Using Nature for the Art of Expression. pp 111–156 Edited by
FernandezJ. M.,
HoefflerJ. P.
San Diego: Academic Press;
VosA.,
MüllerT.,
SchusterP.,
SchlüterH.,
NeubertA.2000; Oral vaccination of foxes against rabies with SAD B19 in Europe, 1983–1998: a review. Veterinary Bulletin 70:1–6
WaltersR. W.,
GrunstT.,
BergelsonJ. M.,
FinbergR. W.,
WelshM. J.,
ZabnerJ.1999; Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. Journal of Biological Chemistry 274:10219–10226
WangY.,
XiangZ.,
PasquiniS.,
ErtlH. C. J.1997; The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus. Journal of Virology 71:3677–3683
XiangZ. Q.,
YangY.,
WilsonJ. M.,
ErtlH. C. J.1996; A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220–227
YamamotoS.,
OmuraM.,
HirataH.1985; Isolation of porcine, canine and feline IgG by affinity chromatography using protein A. Veterinary Immunology and Immunopathology 5:195–200
YaroshO. K.,
WandelerA. I.,
GrahamF. L.,
CampbellJ. B.,
PrevecL.1996; Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine 14:1257–1264
ZabnerJ.,
FreimuthP.,
PugaA.,
FabregaA.,
WelshM. J.1997; Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. Journal of Clinical Investigation 100:1144–1149